Home › Funds › Royce & Associates › IMAX

Royce & Associates position in IMAX

IMAX CORP · Consumer Discretionary

Royce & Associates reported holding 1,251,603 shares of IMAX (IMAX CORP) in its Q3 2026 13F filing — a position valued at US$68.6M, representing 0.63% of its reported portfolio and ranking #17 among its reported holdings. Royce & Associates has disclosed IMAX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)1.25M sh
Reported value held$68.59M
Portfolio Weight0.63%
First reportedQ3 2021
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Royce & Associates's IMAX position evolved

Royce & Associates first disclosed a stake in IMAX in Q3 2021 at 1,075,550 shares (US$20.4M). The position peaked in Q3 2026 at 1,251,603 shares, worth US$68.6M. Across 21 filings, Royce & Associates increased the stake 9 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,251,603 shares valued at US$68.6M — a reduction of -91,625 shares quarter over quarter.. Notable position changes include a 34% trim in Q1 2022 (shares fell 11% over the following quarter), a 47% increase in Q4 2022 (shares rose 31% over the following quarter), a 38% increase in Q1 2024 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.08M $20.41M New
Q4 2021 1.13M $20.13M Add
Q1 2022 746.97K $14.14M Reduce
Q2 2022 755.07K $12.75M Add
Q3 2022 755.07K $10.66M Hold
Q4 2022 1.11M $16.26K Add
Q1 2023 1.23M $23.55K Add
Q2 2023 1.15M $19.51M Reduce
Q3 2023 1.16M $22.34M Add
Q4 2023 1.29M $19.32M Add
Q1 2024 1.78M $28.75M Add
Q2 2024 1.77M $29.65M Reduce
Q3 2024 1.82M $37.38M Add
Q4 2024 1.77M $45.34M Reduce
Q1 2025 1.67M $43.89M Reduce
Q2 2025 1.35M $37.76M Reduce
Q3 2025 1.33M $43.42M Reduce
Q4 2025 1.26M $46.73M Reduce
Q1 2026 1.25M $47.37M Reduce
Q2 2026 1.34M $53.54M Add
Q3 2026 1.25M $68.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMAX and 13F data

IMAX (IMAX CORP) is a Consumer Discretionary company. 36 other funds we track also report a position in IMAX — the largest reported positions include Orbis Allan Gray Ltd (US$162.5M), CONGRESS ASSET MANAGEMENT CO (US$139.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$128.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMAX

All IMAX fund holders →

FAQ

How long has Royce & Associates held IMAX?

Royce & Associates has disclosed IMAX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Royce & Associates's current position in IMAX?

As of Q3 2026, Royce & Associates holds 1.25M shares of IMAX (IMAX CORP), valued at $68.59M, representing 0.63% of its reported portfolio and ranking #17.

Has Royce & Associates been buying or selling IMAX?

In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in IMAX. The position peaked in Q3 2026 at 1.25M shares.

Which other funds hold IMAX?

Other major institutional holders of IMAX include Orbis Allan Gray Ltd, CONGRESS ASSET MANAGEMENT CO, DRIEHAUS CAPITAL MANAGEMENT LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.